Literature DB >> 711852

Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis.

C J Jaffe, J M Vierling, E A Jones, T J Lawley, M M Frank.   

Abstract

An approach to the assessment of reticuloendothelial function that quantitates clearance specifically mediated by membrane receptors for C3b and immunoglobulin (Ig)G has been applied in man. Clearance of isologous erythrocytes coated with IgM or C3b or coated with IgG were examined in patients with primary biliary cirrhosis (PBC), chronic hepatitis, or alcoholic cirrhosis and normal control subjects and compared with the clearance of aggregated human serum albumin. Clearance of these three types of particles varied independently. None of the patients studied had a defect in the clearance of aggregated albumin. No patient with PBC (0:6) had delayed clearance of IgG-coated erythrocytes; one of six patients with chronic hepatitis had delayed clearance of these cells. Indeed, four of six with PBC had increased rates of IgG-mediated clearance. In contrast, six out of six patients with PBC had an unequivocal defect in clearance mediated by C3b receptors. The patients with PBC varied widely in terms of duration of symptoms, degree of cholestasis, and histologic stage of disease. No defect of C3b-mediated erythrocyte clearance was found in the patients with chronic hepatitis or alcoholic cirrhosis. Furthermore, a patient with severe cholestasis secondary to large duct biliary obstruction exhibited normal C3b-mediated clearance. The defect in C3b-mediated clearance in PBC did not correlate with serum levels of individual complement components or inhibitors or with the presence of circulating immune complexes as measured by the Clq precipitation assay. Thus, measurements of receptor specific clearance, but not clearance of aggregated proteins, have revealed a highly specific defect in reticuloendothelial function in PBC.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 711852      PMCID: PMC371867          DOI: 10.1172/JCI109212

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Studies of the reticuloendothelial system (RES). II. Changes in the phagocytic capacity of the RES in patients with certain infections.

Authors:  H N WAGNER; M IIO; R B HORNICK
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808

2.  The measurement of liver circulation by means of the colloid disappearance rate. I. Liver blood flow in normal young men.

Authors:  E L DOBSON; G F WARNER; C R FINNEY; M E JOHNSTON
Journal:  Circulation       Date:  1953-05       Impact factor: 29.690

Review 3.  NIH conference. Pathophysiology of immune hemolytic anemia.

Authors: 
Journal:  Ann Intern Med       Date:  1977-08       Impact factor: 25.391

4.  Antibody to hepatitis-B-virus core in man.

Authors:  J H Hoofnagle; R J Gerety; L F Barker
Journal:  Lancet       Date:  1973-10-20       Impact factor: 79.321

5.  Immune complexes in acute and chronic liver disease.

Authors:  H C Thomas; D De Villiers; B Potter; H Hodgson; S Jain; D P Jewell; S Sherlock
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

Review 6.  Immunopathology of viral hepatitis in man.

Authors:  W D Reed; A L Eddleston; R Williams
Journal:  Prog Med Virol       Date:  1974

7.  Circulating immune complexes and complement activation in primary biliary cirrhosis.

Authors:  J R Wands; J L Dienstag; A K Bhan; E R Feller; K J Isselbacher
Journal:  N Engl J Med       Date:  1978-02-02       Impact factor: 91.245

8.  The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man.

Authors:  C J Jaffe; J P Atkinson; M M Frank
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

9.  Exploration of the phagocytic function of the reticuloendothelial system with heat denatured human serum albumin labeled with I131 and application to the measurement of liver blood flow, in normal man and in some pathologic conditions.

Authors:  G BIOZZI; B BENACERRAF; B N HALPERN; C STIFFEL; B HILLEMAND
Journal:  J Lab Clin Med       Date:  1958-02

10.  Serum complement in chronic liver disease.

Authors:  B J Potter; A M Trueman; E A Jones
Journal:  Gut       Date:  1973-06       Impact factor: 23.059

View more
  31 in total

Review 1.  Regulation of macrophage phagocytosis.

Authors:  D L Coleman
Journal:  Eur J Clin Microbiol       Date:  1986-02       Impact factor: 3.267

2.  Demonstration of hepatic Fc receptor function in vivo.

Authors:  N Yousaf; J C Howard; B D Williams
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  Role of splenectomy in the pathogenesis of Haemophilus influenzae type f meningitis.

Authors:  F P Meier; F A Waldvogel; A Zwahlen
Journal:  Eur J Clin Microbiol       Date:  1985-12       Impact factor: 3.267

4.  Killed Escherichia coli stimulates macrophage-mediated alterations in hepatocellular function during in vitro coculture: a mechanism of altered liver function in sepsis.

Authors:  M A West; G A Keller; F B Cerra; R L Simmons
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

5.  Influence of antigen on immune complex behavior in mice.

Authors:  D S Finbloom; D B Magilavy; J B Harford; A Rifai; P H Plotz
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

6.  A new look at reticuloendothelial blockade.

Authors:  J W Bradfield
Journal:  Br J Exp Pathol       Date:  1980-12

7.  Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis.

Authors:  G W Hunninghake; J E Gadek; T J Lawley; R G Crystal
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

8.  The splenic extraction ratio of antibody-coated erythrocytes and its response to plasma exchange and pulse methylprednisolone.

Authors:  M J Walport; A M Peters; K B Elkon; C D Pusey; J P Lavender; G R Hughes
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

9.  Imaging and assessment of regional clearances of indium-111 labelled circulating immune complexes in humans.

Authors:  E Wirquin; C Bruneau; M Meignan; L Cinotti; A Sobel
Journal:  Eur J Nucl Med       Date:  1986

10.  Complement activation in chronic liver disease.

Authors:  L E Munoz; D De Villiers; D Markham; K Whaley; H C Thomas
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.